Progyny (NASDAQ:PGNY) Issues FY 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.540-1.570 for the period, compared to the consensus earnings per share estimate of 0.710. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Progyny also updated its Q4 guidance to $0.07-0.10 EPS.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 target price on shares of Progyny in a research report on Tuesday, October 1st. JMP Securities lowered shares of Progyny from an “outperform” rating to a “market perform” rating in a research report on Thursday, September 19th. Canaccord Genuity Group decreased their price target on Progyny from $24.00 to $18.00 and set a “hold” rating on the stock in a research note on Friday, September 20th. Leerink Partnrs downgraded Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group lowered their target price on Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $27.73.

Progyny Stock Up 0.7 %

Shares of Progyny stock opened at $17.18 on Wednesday. The firm has a market cap of $1.55 billion, a PE ratio of 27.27, a P/E/G ratio of 1.61 and a beta of 1.44. Progyny has a fifty-two week low of $13.93 and a fifty-two week high of $42.08. The business’s fifty day moving average is $17.88 and its two-hundred day moving average is $23.62.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.